Stories
Slash Boxes
Comments

SoylentNews is people

posted by mrpg on Saturday February 09 2019, @07:01AM   Printer-friendly
from the good dept.

Ahead of potential regulation, Johnson & Johnson will include the list and potential out-of-pocket prices of the drugs it sells in television commercials, beginning with Xarelto (rivaroxaban):

Johnson & Johnson said on Thursday it will start adding the price of its medicines to television commercials by next month, becoming the first drugmaker to heed a call by U.S. President Donald Trump for price transparency of drugs advertised directly to consumers on TV.

The healthcare conglomerate said it will include both the list price of a product - the price before any rebates or discounts to insurers or pharmacy benefit managers - as well as potential out-of-pocket costs that patients will pay.

The move, announced in a statement on J&J's website, won swift praise from U.S. Health and Human Services Secretary Alex Azar. Last May, Azar's office released a blueprint for reducing the cost of drug prices, which included a proposal to require disclosure of list prices in TV ads for drugs.

[...] Republican Senator Chuck Grassley, chairman of the Senate Finance Committee, and Democratic Senator Ron Wyden, ranking member of the committee, on Monday invited executives from seven pharmaceutical companies, including J&J, to testify at a Feb. 26 hearing on rising drug prices.

Also at MarketWatch.


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 0) by Anonymous Coward on Saturday February 09 2019, @09:24AM (2 children)

    by Anonymous Coward on Saturday February 09 2019, @09:24AM (#798763)
  • (Score: 3, Informative) by Pino P on Saturday February 09 2019, @02:25PM

    by Pino P (4721) on Saturday February 09 2019, @02:25PM (#798819) Journal

    images.thetruthaboutcars.com uses an invalid security certificate.

    The certificate is only valid for the following names: [list of 100 names that includes thetruthaboutcars.com and www.thetruthaboutcars.com but not images.thetruthaboutcars.com]

  • (Score: 2) by toddestan on Sunday February 10 2019, @07:40PM

    by toddestan (4982) on Sunday February 10 2019, @07:40PM (#799181)

    Honda is kind of known for charging full MSRP for their cars, take it or leave it. If you're getting any kind of significant discount, it's either something they are having trouble moving, or its a leftover model from the previous year. That is also why it's somewhat rare to see Honda's being used as a fleet car, because fleet managers don't want to pay MSRP for a fleet of vehicles. With that said, I don't know what is going on with the attached image - looks like a bunch of overpriced dealer add-ons to me.

    On the other hand, you have GM which (except when Saturn was around) pretty much sells every vehicle at thousands off of MSRP to make it feel like you're getting a deal. If you buy a GM car and pay full MSRP either it's a new model that's really in demand, or you special ordered something.